GlassScriptPhysician profile
Stephanie Rice
NPI 1346668225
$3,207.16
in general payments reported to CMS, 2019-2025
45 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 87% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.82 · 2022: $371 · 2023: $549 · 2024: $874 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,598 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,598.20 |
| Travel and Lodging | $222.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $337.16 | 2023-2025 | Imfinzi, Enhertu, Lynparza |
| Visionrt, INC. | $286.88 | 2025 | |
| Novartis Pharmaceuticals Corporation | $250.05 | 2022-2025 | |
| Daiichi Sankyo INC. | $174.55 | 2022-2025 | Enhertu, Vanflyta |
| Genzyme Corporation | $152.41 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $138.67 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $134.64 | 2023-2025 | |
| Genentech USA, INC. | $128.84 | 2023-2025 | Phesgo, Gavreto, Columvi |
| Regeneron Healthcare Solutions, INC. | $111.94 | 2024-2025 | Libtayo |
| Histosonics, INC. | $96.57 | 2025 | |
| Stryker Corporation | $93.19 | 2025 | Molli |
| Siemens Medical Solutions USA, INC. | $73.33 | 2025 | Varian Identify |
| Incyte Corporation | $72.54 | 2023-2024 | Jakafi, Monjuvi, Pemazyre |
| Seagen INC. | $71.98 | 2022-2023 | Adcetris, Tukysa |
| Bayer Healthcare Pharmaceuticals INC. | $68.69 | 2022-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.